Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

OpenMIND

Financiado

Opto-Electronic Neural Connectoid Model Implemented for Neurodegenerative Diseas...

Opto-Electronic Neural Connectoid Model Implemented for Neurodegenerative Disease A major challenge facing Europe is its ageing population and associated increase in diagnosed cases of neurodegenerative diseases (NDD). Parkinson’s disease (PD) is associated with tremor and loss of motor functions due to progres... ver más

31/10/2025

TECHNICAL UNIVERSI...

3M€

Presupuesto del proyecto: 3M€

Líder del proyecto

DANMARKS TEKNISKE UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 5 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-06-30

HORIZON-EIC-2021-PATHFINDEROPEN-01-01: EIC Pathfinder Open 2021 Scope:You should apply to this call if you are looking for support from EIC Pathfinder Open to reali...

I+D

Cerrada hace 3 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

5 Participantes

TECHNICAL UNIVERSITY OF DENM...

1.23M€ | Lider

LUNDS UNIVERSITET

669.99K€ | Participante

CELLINK BIOPRINTING AB

410.39K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PID2021-127800OA-I00 MARCO METODOLOGICO PARA LA MONITORIZACION ONLINE DE LA DOSIS... 194K€ Cerrado

EIN2020-112391 AUTOMATIZACION DE TERAPIAS AVANZADAS PARA PARKINSON 15K€ Cerrado

PID2019-105017RB-I00 AGREGACION DE PROTEINAS: APLICACIONES BIOMEDICAS Y BIOTECNOL... 290K€ Cerrado

BIO2017-91475-EXP PEPTIDOS HELICOIDALES PARA CURAR LA ENFERMEDAD DE PARKINSON 30K€ Cerrado

SAF2008-01462 OLIGOMERIZACION DE RECEPTORES ACOPLADOS A PROTEINA G EN LOS... 206K€ Cerrado

SAF2009-12241 PROGRESION DE LA ENFERMEDAD DE PARKINSON: CREACION DE UN MOD... 169K€ Cerrado

Duración del proyecto: 40 meses Fecha Inicio: 2022-06-30
Fecha Fin: 2025-10-31

Líder del proyecto

DANMARKS TEKNISKE UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 3M€

Descripción del proyecto A major challenge facing Europe is its ageing population and associated increase in diagnosed cases of neurodegenerative diseases (NDD). Parkinson’s disease (PD) is associated with tremor and loss of motor functions due to progressive degeneration of dopaminergic neurons in the brain. This can lead to memory loss and dementia, which is associated with short- and long-term injuries and disabilities with emotional, financial, and social burdens for patients, families, and society. The exact causes and mechanisms underlying PD are still unknown and existing treatments focus on alleviating symptoms and increasing quality of life, but do not halt or reverse disease progression. Although animal models give unique possibilities to study physiological and behavioural mechanisms, drug development fails due to lack of translation to humans. Alternative non-animal NDD models is needed both in terms of better translation, but also to replace expensive and problematic animal experiments. We will move disease modelling to a new level and replace animal models, by creating a new concept we call connectoids. We will develop an ex-vivo-type in vitro human opto-electronic multi-regional brain-organoid disease model in which connectoids are formed by precise spatial arrangement of brain organoids connected via hydrogel tracts that promote axonal pathfinding, functional connection, and signalling. By developing 1) light controllable sub-type specific neurons within regionalized brain organoids, and 2) electrodes and waveguides that can penetrate the organoids able to monitor neurotransmitter signalling inside and between the organoids, we will for the first time be able to sense how a particular brain region responds to a certain therapy and watch in real time how signals are transmitted to other brain regions. Our model will not only have health benefit, but will relieve a heavy economic burden on society, and open up for new possibilities for technological and economic development.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores